ÂÜÀòÂÒÂ×

Gregory Skalicky, MBA, has an extensive background in the pharmaceutical industry. Gregory currently serves as the President of EVERSANA, overseeing commercial and business development, product launch, and expanding the company's presence in EU/Asia. Prior to this role, Gregory held executive positions at Syneos Health and inVentiv Health, where Gregory managed operational performance and business development activities. Skalicky holds an MBA from Villanova School of Business and a Bachelor of Science in Biology from Temple University.